Biobanks Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Biobanks Market by product & service (equipment, consumables, services and software), sample type (blood products, human tissues, nucleic acids, cell lines, biological fluids and others) and application (regenerative medicine, life science research and clinical research) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Biobanks Market it includes the five years Industry analysis and the 6 years annual forecast from 2018 to 2024. Some of the prominent participants in the Global Biobanks Market are Dickinson and Company, Merck KGaA, Beckman Coulter, Inc, BioLife Solutions, Inc, BioCision and LVL Technologies GmbH & Co. KG. According to report the global biobanks market is projected to grow at a CAGR of 8.2% over the forecast period of 2018-2024.
Get Free Sample Pages of this Premium Report: – https://www.infiniumglobalresearch.com/reports/sample-request/1365
Biobanks are biorepository that accepts, processes, stores and distributes biospecimens and associated data for use in research to improve understanding of health & disease and clinical care. . It covers collections of plant and animal, including human specimens. There has been a tremendous shift in bio-banking over the past 30 years. It started with small, predominantly university-based repositories that were developed to cater the research needs of specific projects. Thereafter, evolved institutional and government supported repositories, commercial (for profit) biorepositories, population based biobanks and most recently, virtual biobanks. Population-wide biobanks is one of the most commonly found biobanks around the globe. It has been developed in several developed countries such as U.S, Canada, Singapore, Japan and many other countries. These population wide biobanks have been created in order to collect, analyze, store phenotypic and genetic information on representative samples of their source populations
Biobanks market was worth XX million in 2017 and is expected to reach XX million by 2024. The samples from biobanks are used for various purposes such as research, therapeutics, clinical trials, and drug development. Factors such as increase in genomic research activities for studying diseases in order to better understand the causes and mechanism of human diseases is a major factor driving the market growth. Also, growing incidence of chronic diseases coupled with increasing demand for cost effective drug to augment the market growth. Furthermore, growing trend of conserving cord blood stem cells of newborns is also boosting the market growth. High cost to maintain biobanks and lack of adequate legislative structures and governance frameworks that regulate the use and development of biobanks are some of the restraints that hinders the market growth. Developing biobanks through partnership with high income countries will help to expand the biobank market in near future
Geographically, North America and Europe has the largest market share in bio-banking market respectively These regions have large number of biobank owing to its plan to establish national genomics research programs. Also, there is huge investment and support from Government and Private Institutes for regenerative medicine research that facilitates growth in this region. Asia Pacific is expected to be the fastest growing region during the forecast period. Huge population base and shifting focus towards development of healthcare infrastructure and growing pharmaceuticals & life sciences companies in emerging countries like China, India and other South East Asian countries can lead Asia Pacific region, to grow at a faster rate. Furthermore many cash-rich established biobank institute, prominently in developed countries are increasingly focused in emerging countries of Asia Pacific to increase its market presence.
The report on global biobanks market covers segments such as, products & service, sample type and application. On the basis of products & service the global biobanks market is categorized into equipment, consumables, services and software. On the basis of sample type the global biobanks market is categorized into blood products, human tissues, nucleic acids, cell lines, biological fluids and others. On the basis of application the global biobanks market is categorized into regenerative medicine, life science research and clinical research.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018-2024.
Get Discount on this Report: https://www.infiniumglobalresearch.com/reports/request-discount/1365
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global biobanks market such as, Tecan AG, Panasonic Healthcare Holdings Co. Ltd, Thermo Fisher Scientific Inc., Taylor-Wharton International LLC, Becton, Dickinson and Company, Merck KGaA, Beckman Coulter, Inc, BioLife Solutions, Inc, BioCision and LVL Technologies GmbH & Co. KG.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global biobanks market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of biobanks market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the biobanks market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the biobanks market to understand the present and future trends in this market and formulate their strategies accordingly.